Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > VaxilBio and CorVax about to drop the V Bomb

<< Previous

Bullboard Posts

Next >>

Comment by Rusty2018on Jan 03, 2021 11:16am

112 Views

Post# 32211360

RE:RE:VaxilBio and CorVax about to drop the V Bomb

at the 41 minute mark David sounds so confident with "we (Vaxil) will be able to price it in a way to afford it for poorer countries"
Vaxil seems to be in a very good position. Not first out of the gate but if as he states safe, effective, inexpensive and easily distributed globally this is a bigger piece of the market.
GLTA

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading